Minnesota Oncology — Minneapolis, Minnesota

Minnesota Oncology is a clinical research site located in Minneapolis, Minnesota, United States 55404.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Minnesota Oncology has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Metastatic Pancreatic Ductal Adenocarcinoma, Locally Advanced or Metastatic Solid Tumors.

Sponsors: Stemline Therapeutics, Inc., Agenus Inc., Chugai Pharmaceutical.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology?

Minnesota Oncology has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology conducted?

Minnesota Oncology has 5 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Metastatic Pancreatic Ductal Adenocarcinoma, Locally Advanced or Metastatic Solid Tumors.

Is Minnesota Oncology accredited by Crixeo Health?

Minnesota Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.